Evaluating the Survival Benefits of Perioperative Chemotherapy in Frail and Morbid Muscle-Invasive Bladder Cancer Patients.
Savin Z, Levin L, Lazarovich A, Rosenzweig B, Shashar R, Hoffman A, Gal J, Haifler M, Pilosov I, Freifeld Y, Shpitzer SA, Golan S, Mano R, Yossepowitch O.
Savin Z, et al. Among authors: hoffman a.
J Pers Med. 2024 Sep 9;14(9):954. doi: 10.3390/jpm14090954.
J Pers Med. 2024.
PMID: 39338209
Free PMC article.